What is the appropriate dose of chlorpheniramine for an 18‑kg female child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Chlorpheniramine Dosing for 18 kg Female Child

For an 18 kg female child, administer chlorpheniramine 2.5 mg every 4-6 hours (IM or IV slowly), not exceeding 15 mg in 24 hours.

Weight-Based Dosing Algorithm

Based on the most authoritative guideline evidence, the dosing follows this structured approach:

Age and Weight Categories 1:

  • 6 months to 6 years: 2.5 mg (IM or IV slowly)
  • 6 to 12 years: 5 mg (IM or IV slowly)
  • > 12 years: 10 mg (IM or IV slowly)

Application to This Patient

An 18 kg child typically falls within the 6 months to 6 years age range (average weight for 4-6 year olds), therefore:

  • Single dose: 2.5 mg
  • Route: IM or IV slowly
  • Frequency: Every 4-6 hours as needed
  • Maximum daily dose: 15 mg (6 doses)

Important Clinical Considerations

Route-Specific Guidance

The evidence consistently supports parenteral administration in acute settings 2, 1. When administering IV, inject slowly to prevent seizures, which can occur with rapid administration 3.

Context Matters

Chlorpheniramine is second-line therapy and should never be used alone for anaphylaxis 2. It is most appropriately used as an adjunct to epinephrine in allergic reactions or for symptomatic relief in other allergic conditions 1.

Common Pitfalls to Avoid

  1. Do not use oral dosing in acute settings: The FDA label 4 provides oral dosing (½ tablet = 2 mg for ages 6-12), but this is for non-emergent outpatient use only

  2. Avoid overdosing: Fatal overdoses have been documented in children, particularly under age 6 5. The 2.5 mg dose is specifically established for safety in this age group

  3. Monitor for sedation: This is the most common adverse effect, particularly prevalent in the 2-5 year age group 6. Be prepared to provide respiratory support if combined with other sedative agents 3

  4. Rapid IV administration risks: Can precipitate seizures and hypotension 3

Pharmacokinetic Rationale

Children demonstrate higher chlorpheniramine clearance (234-470 mL/hr/kg) compared to adults, with a shorter elimination half-life of approximately 9.6 hours 7. This supports the every 4-6 hour dosing interval and explains why children may require relatively higher weight-based doses than adults.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.